Preliminary efficacy of pembrolizumab plus lenvatinib in recurrent clear cell gynecological cancer: Phase II LARA trial (GCGS-OV4/APGOT-OV3).
Saved in:
| Title: | Preliminary efficacy of pembrolizumab plus lenvatinib in recurrent clear cell gynecological cancer: Phase II LARA trial (GCGS-OV4/APGOT-OV3). |
|---|---|
| Authors: | Byoung-Gie Kim1 bgkim@skku.edu, Chel Hun Choi1, Ngoi, Natalie2, Tan, David2, Jae-Weon Kim3 |
| Source: | Journal of Gynecologic Oncology. 2024 Supplement, Vol. 35, p31-32. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
